³Ô¹ÏÍøÕ¾

Latest glioblastoma News

Swedish Cancer Society grants over SEK 40 million to CMB researchers
Nearly 80 million SEK to OnkPat researchers from the Swedish Cancer Society
New Tool Quantifies Cancer’s Ability To Shape-shift
How Scars Of Demolished Brain Tumors Seed Relapse
Noxopharm reports results from Chroma platform drug development program
Scientists exploring more targeted radiation for glioblastoma
Tour de Cure backs further development of Noxopharm’s preclinical brain cancer candidate
Capping off a year of generosity
Chimeric Therapeutics completes placement with shortfall commitments
PERIscope puts research translation on express route
Public support needed to advance treatment in deadly brain cancers
New clue to treat brain cancer
Brain cancer linked to nuclear pore alterations
Efficient Boron Neutron Capture Therapy for Brain Tumor with Novel Boron Carrier
Long-range neuronal connections drive glioblastoma invasion
Chimeric Therapeutics announces new trial for CHM 1101 in glioblastoma
Nanoparticles deliver brain cancer treatment
Kazia Therapeutics participates in ‘Cancer Moonshot Brain Cancers’ forum
KAZIA CEO, DR JOHN FRIEND PARTICIPATES IN WHITE HOUSE CANCER MOONSHOT FORUM Brain Cancers Forum on Glioblastoma & Diffuse Intrinsic Pontine Glioma Forum
Chimeric Therapeutics announces new capital raise
Hunting brain cancer cells
QIMR and WEHI take home prizes for best early-stage project
Collaborative brain cancer research awarded $4.6m grant
$5.4 million boost for brain cancer research
Experimental brain cancer drug fast tracked in clinical trials
Ludwig Lausanne study identifies potential combination therapy for testing in deadly brain cancer
Brain tumour bank boosts research efforts
New orphan drug designation for Kazia Therapeutics’ paxalisib
Fast-tracked: First in-human trial for aggressive brain tumours
Kazia Therapeutics to be ‘transformed’ by pipeline progress
Radiometals and Radiohalogens: Potential New Combination for Cancer Treatment
New drug offers hope for pancreatic cancer patients
UniSA awarded $5.2 million to fight glioblastoma, breast cancer, diabetic foot ulcers and multiple myeloma
Powerful technique details brain tumors’ resiliency
New hope for Australians living with brain cancer
White blood cells may cause tumor cell death — but that’s not good news
China Grand Pharma signs A$400m commercial partnership with Telix Pharma
Researchers join project to understand sex differences in brain cancer outcomes
Certain CBD oils no better than pure CBD at inhibiting certain cancer cell lines
Funds support new brain cancer investigation
Clinical trial gives hope to patients with brain cancer
Ludwig study shows free-floating circles of DNA are common across cancers and drive poor patient outcomes
Blocking copper uptake in tumour cells may help boost immune system and fight deadliest of cancers
Blocking copper uptake in tumour cells may be clue to boosting immune system – fighting deadliest of cancers
Potential new treatment for brain cancer
Brain cancer clinical trial gives hope to patients
University spin-off Empirica Therapeutics acquired by U.S. firm
Ludwig Cancer Research study finds reprogramming of immune cells enhances effects of radiotherapy